Table 3 Proportions of eligible patients receiving guideline-based therapies by categories of estimated glomerular filtration rate.
Treatment | GFR ≥ 90 (n = 626) | GFR 60- < 90 (n = 1073) | GFR 30- < 60 (n = 530) | GFR < 30 (n = 197) | p (trend) |
|---|---|---|---|---|---|
Acute aspirin | 98% | 96% | 97% | 93% | 0.019 |
Acute beta blocker | 94% | 92% | 90% | 89% | 0.166 |
Discharge aspirin | 94% | 95% | 92% | 86% | < 0.001 |
Discharge beta blocker | 91% | 93% | 91% | 89% | 0.389 |
Discharge ACE/ARB | 84% | 92% | 81% | 56% | < 0.001 |
Discharge statin | 83% | 84% | 76% | 69% | < 0.001 |